Oral Fluconazole 150 mg at 27 Weeks Gestation Should Be Avoided
Fluconazole 150 mg should be avoided at 27 weeks gestation, and topical azole antifungals should be used instead as first-line therapy for vulvovaginal candidiasis during pregnancy. 1
FDA Warning and Pregnancy Classification
The FDA drug label explicitly states that fluconazole use in pregnancy should be avoided except in patients with severe or potentially life-threatening fungal infections, where the anticipated benefit outweighs the possible risk to the fetus 1. The label warns that:
- Epidemiological studies suggest a potential risk of spontaneous abortion and congenital abnormalities in infants whose mothers were treated with 150 mg of fluconazole as a single or repeated dose in the first trimester 1
- While your patient is in the second trimester (27 weeks), the FDA guidance emphasizes caution throughout pregnancy
- Case reports describe distinct congenital anomalies with high-dose fluconazole (400-800 mg/day), but concerns exist even at the 150 mg dose 1
Evidence on Pregnancy Risks
Recent systematic reviews and meta-analyses provide important context:
- A 2024 meta-analysis found that while adjusted estimates showed no significant increase in overall major congenital malformations with any fluconazole use, there was a significant association with miscarriages (OR 1.60) 2
- A 2019 Canadian study demonstrated that even low-dose fluconazole (≤150 mg) was associated with increased risk of spontaneous abortion (adjusted OR 2.23) 3
- Multiple studies confirm increased risks of cardiac septal defects and other heart malformations, particularly with doses >150 mg 3, 4
Recommended Alternative Approach
Use topical intravaginal azole antifungals instead, which are considered first-line therapy for vulvovaginal candidiasis during pregnancy 5:
- Clotrimazole 1% cream 5g intravaginally daily for 7-14 days
- Miconazole 2% cream 5g intravaginally daily for 7 days
- Terconazole 0.4% cream 5g intravaginally daily for 7 days (prescription)
These topical agents are effective and avoid systemic exposure to the fetus 5.
Critical Caveats
- The only scenario where oral fluconazole might be justified in pregnancy is for severe or potentially life-threatening fungal infections (e.g., invasive candidiasis, cryptococcal meningitis) where maternal mortality risk outweighs fetal risk 1
- Simple vulvovaginal candidiasis at 27 weeks does not meet this threshold
- If fluconazole were absolutely necessary, effective contraceptive measures should continue for approximately 1 week (5-6 half-lives) after the final dose in women of childbearing potential 1